Red Sox’ Chris Sale Receives PRP Injection, Will Be Re-Evaluated in Six Weeks

After it was revealed that left-hander Chris Sale would not need Tommy John Surgery, the Red Sox announced that the 30-year-old received a platelet-rich plasma injection during his visit with Dr. James Andrews on Monday.

Dr. Andrews confirmed that Sale did indeed have inflammation in his throwing elbow prior to the injection, and recommended a shutdown period of six weeks before being re-evaluated once more.

Here’s the official statement from Red Sox president of baseball operations Dave Dombrowski.

As you may have already figured out, six weeks from now is September 30th, meaning that Sale’s 2019 season is likely over. Dombrowski confirmed that himself, per MLB.com’s Ian Browne.

If that is indeed the case, the Florida native’s third year with Boston was rather underwhelming.

In 25 starts, Sale posted a 4.40 ERA and .221 batting average against over 147 1/3 innings pitched, presumably ending his run of seven straight seasons finishing in the top seven for American League Cy Young Award voting. The Red Sox went 10-15 in those games.

As mentioned earlier, Sale will be re-evaluated by Dr. Andrews in late September. For now, the Red Sox need to find someone to take their ace’s spot in the starting rotation.

Advertisements

Author: Brendan Campbell

Blogging about the Boston Red Sox since April '17. Also support Tottenham Hotspur.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s